SecProbe.io - Filing

CORRESP Filing

Propanc Biopharma, Inc.
Date: April 16, 2026 · CIK: 0001517681 · Accession: 0001493152-26-017000

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-295002

Date

April 10, 2026

Author

Chief

Form

CORRESP

Company

Propanc Biopharma, Inc.

Letter

Re: Propanc Biopharma, Inc.

April 16, 2026

United States Securities and Exchange Commission

Division of Corporation Finance

Attn: Tyler Howes

F Street, N.E.

Washington, DC 20549

Registration Statement on Form S-1

Filed April 10, 2026

File No. 333-295002

Ladies and Gentlemen:

The undersigned registrant (the "Registrant") hereby requests that the Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on April 20, 2026 at 12:00 p.m. Eastern Daylight Time, or as soon thereafter as practicable.

The Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772 with any questions.

Very
truly yours,
Propanc
Biopharma, Inc.

Show Raw Text

CORRESP
 1
 filename1.htm

 April
16, 2026

 United
States Securities and Exchange Commission

 Division
of Corporation Finance

 Attn:
Tyler Howes

 100
F Street, N.E.

 Washington,
DC 20549

 Re:
 Propanc
 Biopharma, Inc.

 Registration
 Statement on Form S-1

 Filed
 April 10, 2026

 File
 No. 333-295002

 Ladies
and Gentlemen:

 The
undersigned registrant (the "Registrant") hereby requests that the Securities and Exchange Commission (the "Commission")
take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on April 20, 2026 at 12:00
p.m. Eastern Daylight Time, or as soon thereafter as practicable.

 The
Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the
requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772
with any questions.

 Very
truly yours,

 Propanc
 Biopharma, Inc.

 /s/
 James Nathanilesz

 James
 Nathanilesz

 Chief
 Executive Officer